Gilmour Space Technologies launches rocket ship in Australian first
About 8.30am on Wednesday, Gilmour Space Technologies made history when its first orbital rocket, Eris, launched from Bowen in North Queensland.
It recorded 14 seconds of flight before crashing back to the ground, a move that was intended by the team.
Speaking to the The Courier-Mail, co-founder and chief executive officer Adam Gilmour said he was 'happy' with the test flight result.
The rocket had been sitting at the spaceport for more than a year, with numerous attempts to launch made in early 2025.
However, previous test flight attempts were postponed due to external factors, including strong winds and technical issues.
'The rocket wasn't designed to (sit in one spot), and we wanted to get off the pad at minimum,' he told the outlet.
'We had all four engines fire off nicely, we avoided the pad, the rocket is off the pad now and no visible damage to the pad.'
Mr Gilmour said since the rocket avoided landing on the pad, the company would likely be able to launch a second test flight in about six months.
Online, the Gilmour Space Technologies crew said the test flight was a 'big step for (Australian) launch capability'.
'Team safe, data in hand, eyes on TestFlight 2,' the post read.
Mr Gilmour said it was 'almost unheard of' for a private company to launch a rocket ship to orbit the first time around.
'What's important is that every second of flight will deliver valuable data that will improve our rocket's reliability and performance for future launches,' he said.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Sydney Morning Herald
10 minutes ago
- Sydney Morning Herald
Australian cancer breakthrough could mean an end to relapse for thousands, including Colette
Collette Chase says the hardest part of finishing breast cancer treatment is the fear that the disease will return. 'Even Princess Kate said it recently ... you just live in a ball of anxiety,' said Chase, who is in her 50s. 'People will say to you, 'Ah look, you could get hit by a bus tomorrow'. I'd choose that because if this comes back metastatic as stage 4, what's [the treatment] going to do to me?' Australian scientists are hoping to alleviate this fear and halve breast cancer recurrence by utilising new technology that allows them to find, isolate and study the rare cancer cells lying dormant in people's bones. Loading Garvan Institute researchers have discovered how to find the previously undetectable cells, and their technology will be used in a $25 million research project to learn how they hide, how they are different, why they 'wake up' and how they can be destroyed beforehand. It has potential to be applied to our understanding of why other cancers return. Despite dramatically improved survival rates, about 15 per cent of breast cancer patients will experience a recurrence of it within 10 years, which can be fatal. This is because rare 'seeds' of cancer can conceal themselves, most often in bones, and remain dormant for years, sometimes decades. A team of 60 researchers from seven Australian institutes and organisations, the Universities of Sydney and Newcastle, multiple Australian hospitals and universities, plus Yale and Washington universities, have been awarded the National Breast Cancer Foundation's biggest grant for the project, dubbed AllClear.
The Age
10 minutes ago
- The Age
Australian cancer breakthrough could mean an end to relapse for thousands, including Colette
Collette Chase says the hardest part of finishing breast cancer treatment is the fear that the disease will return. 'Even Princess Kate said it recently ... you just live in a ball of anxiety,' said Chase, who is in her 50s. 'People will say to you, 'Ah look, you could get hit by a bus tomorrow'. I'd choose that because if this comes back metastatic as stage 4, what's [the treatment] going to do to me?' Australian scientists are hoping to alleviate this fear and halve breast cancer recurrence by utilising new technology that allows them to find, isolate and study the rare cancer cells lying dormant in people's bones. Loading Garvan Institute researchers have discovered how to find the previously undetectable cells, and their technology will be used in a $25 million research project to learn how they hide, how they are different, why they 'wake up' and how they can be destroyed beforehand. It has potential to be applied to our understanding of why other cancers return. Despite dramatically improved survival rates, about 15 per cent of breast cancer patients will experience a recurrence of it within 10 years, which can be fatal. This is because rare 'seeds' of cancer can conceal themselves, most often in bones, and remain dormant for years, sometimes decades. A team of 60 researchers from seven Australian institutes and organisations, the Universities of Sydney and Newcastle, multiple Australian hospitals and universities, plus Yale and Washington universities, have been awarded the National Breast Cancer Foundation's biggest grant for the project, dubbed AllClear.
9 News
26 minutes ago
- 9 News
Top-selling electric vehicles falling short on battery range, study says
Your web browser is no longer supported. To improve your experience update it here Some of the most widely sold electric vehicles in Australia are being promoted with misleading details about their battery range, new research shows. Real-world testing by the Australian Automobile Association (AAA) found the actual driving distance of some EVs fell short by up to 100km. The poorest-performing vehicle was the Chinese-built BYD ATTO3. Researchers tested a 2023 model of the SUV, and it fell 23 per cent short of its advertised range, or about 100km. Popular electric cars in Australia fell short on their battery range advertised by vehicle manufacturers, new research shows. (Supplied) The 2022 Kia EV 6 and the 2024 Telsa Model Y both had driving ranges of 8 per cent less in the real-world tests than recorded in laboratory tests. The 2024 Tesla Model 3 had a real-world range of 441km on a full charge, 14 per cent less than the 513km achieved in the lab. The 2024 Smart #3 EV performed closest to its laboratory test result with a real-world driving range of 432km – 5 per cent, or 23km, less than recorded in its mandatory laboratory test. Data from the federal government-funded testing reinforces an AAA survey of EV drivers last month that found concerns about driving range and recharging was the biggest challenge when they came to purchase a new car. AAA managing director Michael Bradley said the results would help potential EV buyers. "As more EVs enter our market, our testing will help consumers understand which new market entrants measure up on battery range," Bradley said. The Tesla Model 3 was among the cars tested by the AAA. (Supplied) NRMA spokesperson Peter Khoury told Today this morning testing of EVs needed to continue as the technology gains popularity. "It is now up to the manufacturers to make sure that they're putting in batteries that deliver what they promised, because there's a lot of EVs on the market," he said. "It will be competitive." motoring renewable energy Australia Research Electricity CONTACT US
